SIDEROS
SideROS bridges innovative research on iron-targeting chemical compounds and drug candidate discoveries to target persister cancer cells, refractory to conventional treatments, and associated with metastasis and relapse.
SIDEROS
Industry:
Biotechnology
Founded:
2019-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.sideros.bio
Total Employee:
1+
Status:
Active
Total Funding:
1.13 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache
Similar Organizations
Faze Medicines
Faze Medicines is a biotechnology company.
Geneius
Geneius is a Biotechnology company.
Neomorph
Neomorph is a biotechnology company.
Repertoire Genesis
Repertoire Genesis is a biotechnology company.
Step Pharma
Step Pharma is a biotechnology company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Investors List
Bpifrance
Bpifrance investment in Debt Financing - SideROS
Région Ile-de-France
Région Ile-de-France investment in Grant - SideROS
Key Employee Changes
| Date | New article |
|---|---|
| 2021-05-25 | Sidero appoints Wayne Byrne as Chief Commercial Officer |
Official Site Inspections
http://www.sideros.bio
- Host name: 172.67.210.238
- IP address: 172.67.210.238
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "SideROS"
SideROS - Crunchbase Company Profile & Funding
Contact Email [email protected] SideROS bridges innovative research on iron-targeting chemical compounds and drug candidate discoveries to target persister cancer cells, …See details»
SideRos 2025 Company Profile: Valuation, Funding & Investors
SideRos General Information Description. Operator of a biotechnology company intended to improve the conditions of patients affected by life-threatening diseases. The company bridges …See details»
SideROS | LinkedIn
SideROS | 698 followers on LinkedIn. Focus on accelerated development of innovative small molecules targeting tumor cells metabolism in high-risk cancers | SideROS is a preclinical …See details»
SideROS raised €1 Million funding to accelerate the development …
Starting from September 2020, SideROS will integrate Paris Biotech Santé incubator, to get expertise from their network in the complex field of drug development in oncology and support …See details»
TACKLE RELAPSE & METASTASIS IN CANCER
[email protected] +33 6 62 59 04 17. Created Date: 20200526173154Z ...See details»
SideROS | Paris, France Startup - gust.com
SideROS is a preclinical stage biotech company focused on accelerated development of innovative drug candidates for patients affected by high risk cancers ... Founded January 2019 …See details»
SideROS, la deeptech qui offre une alternative à la ... - Bpifrance
Jun 10, 2025 Depuis 2019, la deeptech SideROS développe, à partir d’une molécule de synthèse un nouveau traitement contre les récidives de cancers, ciblant les cellules …See details»
SideROS - Overview, News & Similar companies | ZoomInfo.com
View SideROS (sideros.bio) location in Ile-de-France, France , revenue, industry and description. Find related and similar companies as well as employees by title and much more. Products. ...See details»
Sideros SAS - Drug pipelines, Patents, Clinical trials - Synapse
Explore Sideros SAS with its drug pipeline, therapeutic area, technology platform, .See details»
SideROS: le fer contre les récidives et métastases en cancer
SideROS développe de nouvelles stratégies anticancéreuses qui ciblent le fer contenu dans les cellules souches cancéreuses résistantes aux traitements conventionnels et responsables des ...See details»
SideROS | EuroQuity
About your organization / profile SideROS is a preclinical stage biotech focused on iron interfering drug candidates development for patients at high-risk of relapse and metastasis. Preclinical …See details»
SideROS | BIO-Europe Spring - Informa Connect
SideROS aims to tackle relapse and metastasis, enabling the complete remission of any cancer and improving the conditions of patients affected by life-threatening diseases effective …See details»
SideROS company information, funding & investors | Dealroom.co
SideROS, focused on accelerated development of innovative small molecules targeting tumour cells metabolism in high-risk cancers. Here you'll find information about their funding, investors …See details»
Startup SIDEROS Medtech innovante contre les cellules …
Medtech innovante contre les cellules cancéreuses persistantes. SideROS a été fondée en janvier 2019 sur la base des recherches du Dr Raphaël Rodriguez, un scientifique de …See details»
SideROS - Company Profiles - BCIQ
For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, …See details»
SideROS - Products, Competitors, Financials, Employees, …
SideROS is a community-focused platform specializing in the online slot and casino gaming industry. Use the CB Insights Platform to explore SideROS's full profile. ... sideros.bio. …See details»
SideROS : actu, infos, fiche entreprise - Maddyness
SideROS, fondée en 2019 par Raphaël Rodriguez et Robin Rivaton, est une entreprise de biotechnologie spécialisée en oncologie. Elle développe une approche thérapeutique …See details»
SideROS - Contacts, Employees, Board Members, Advisors & Alumni
SideROS is a biotechnology company. Start Free Trial . Chrome ExtensionSee details»
SideROS - Funding, Financials, Valuation & Investors - Crunchbase
SideROS is a biotechnology company. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. ... How much funding has this organization raised over …See details»
Welcome to BIO 2025: Collaboration can't wait. | BIO
1 day ago As we kick off BIO 2025, the world’s largest biotech gathering, BIO emphasizes that collaboration can’t wait. Today’s theme: Collaboration—between government and industry, …See details»